| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.5 | 5e-05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.094 | 0.001 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.007 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.087 | 0.008 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |